Prostate Cancer: Man’s Plea for Screening After Late Diagnosis | UK News

The call for greater awareness and proactive testing for prostate cancer is growing, particularly within the Black community, where men face a significantly higher risk of developing and dying from the disease. Recent accounts, including that of Tony Collier, a man diagnosed with incurable prostate cancer, highlight the potential impact of earlier detection. Collier’s story underscores a critical point: a simple PSA blood test could have altered his prognosis dramatically.

A Delayed Diagnosis and a Lost Two Years

Tony Collier, a former ultra-marathon runner, received a stage four prostate cancer diagnosis in 2017 after seeking medical attention for a groin strain. He recalls the shock of learning his cancer was incurable and the initial prognosis of just two to three years to live. “Being told you have cancer is devastating; being told it’s incurable is indescribable and you immediately go to a very dark place,” he said. He initially focused on preparing for death, a mindset he later realized was detrimental to truly living during the time he had. His wife, Tracey, urged him to make the most of each day, reminding him that simply surviving meant he hadn’t wasted the precious time he had been given.

Collier believes that if he had received a PSA test ten years prior, his outcome could have been vastly different. “If I’d had that simple blood test I could be in a totally different position now, instead of being given a worst case prognosis of two to three years,” he stated. This sentiment is echoed by many advocates who believe wider access to, and awareness of, PSA testing is crucial.

Disparities in Prostate Cancer Outcomes

While prostate cancer is the most common cancer in men, its impact is not felt equally across all populations. Black men are at a higher risk of developing prostate cancer and are more likely to die from it than men of other racial and ethnic groups. The American Cancer Society reports that Black men are more than twice as likely to die from prostate cancer as White men. The reasons for this disparity are complex and likely involve a combination of genetic factors, socioeconomic conditions, and access to healthcare.

The PSA Test: A Point of Contention

The prostate-specific antigen (PSA) test is a blood test that measures the level of PSA in the blood. Elevated PSA levels can indicate the presence of prostate cancer, but can too be caused by other conditions, such as benign prostatic hyperplasia (BPH) or prostatitis. The test is not without its limitations, including the potential for false positives, leading to unnecessary biopsies, and false negatives, potentially delaying diagnosis.

Recently, the UK National Screening Committee decided against recommending mass screening on the NHS for prostate cancer, despite calls from advocates like Collier. This decision has sparked debate, with many arguing that the benefits of early detection outweigh the risks, particularly for high-risk groups like Black men. The committee will finalize its recommendations later this month following a consultation that closed in February.

Beyond Screening: Awareness and Advocacy

Collier’s experience highlights the importance of awareness and proactive health-seeking behavior. He is now dedicated to ensuring that fewer men experience a similar outcome. “It’s really important that we save as many men’s lives as possible. And 12,000 men are dying every year. That’s one every 45 minutes,” he emphasizes. He believes that increased awareness, coupled with a future screening program, is the key to reducing prostate cancer mortality rates.

Currently, awareness remains the primary tool for early detection. Men, particularly those over 50 and those with a family history of prostate cancer, should discuss their risk factors with their doctor and consider whether a PSA test is appropriate for them. Tackle Prostate Cancer is one organization actively working to raise awareness and provide support for men affected by the disease. Tony Collier is a committed advocate for the organization, as well as an ambassador for Prostate Cancer UK and one of the administrators of a large online Facebook Prostate Cancer Support Group.

The Importance of Present-Moment Living

The emotional toll of a cancer diagnosis, particularly an advanced one, can be immense. Collier’s story also serves as a powerful reminder of the importance of mental and emotional wellbeing. His wife’s encouragement to focus on living, rather than dwelling on a potential future, proved pivotal in helping him reclaim his joy and purpose. This underscores the need for comprehensive support services for cancer patients and their families, addressing not only the physical aspects of the disease but also the psychological and emotional challenges.

What’s Next: Awaiting Screening Recommendations

The final recommendations from the UK National Screening Committee are expected later this month. These recommendations will inform government policy and potentially shape the future of prostate cancer screening in the UK. In the meantime, continued advocacy and awareness campaigns are crucial to empower men to take control of their health and seek early detection. The conversation around prostate cancer screening is evolving, and the voices of those directly affected, like Tony Collier, are essential in driving meaningful change. Manchester Magazine recently profiled Collier’s journey, further amplifying his message.

For more information about prostate cancer, risk factors, and screening options, consult with a qualified healthcare professional and refer to reputable sources such as the NHS website and the Cancer Research UK website.